BioSpace News Archive

Drug Development

Clovis Oncology Presents Patient-Centered Outcomes Data from Phase 3 ARIEL3 Study for Rubraca®▼ in Advanced Ovarian Cancer

Quality-adjusted progression free survival (QA-PFS) and quality-adjusted time without cancer related symptoms or toxicity (Q-TWiST) demonstrate the benefit of Rubraca maintenance treatment over placebo from a patient perspective

May 20, 2019
·
13 min read
Deals

Thermo Fisher Scientific to Invest $50 Million to Expand Bioproduction Capabilities

Thermo Fisher Scientific Inc., the world leader in serving science, announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container systems.

May 20, 2019
·
2 min read
Business

Stability Growth Announces Hire of David Lewis as chief operating officer

Stability Growth announces the addition of seasoned executive David Lewis as chief operating officer and hiring plans for 20 additional full-time employees.

May 20, 2019
·
2 min read
Business

Lyme Disease Diagnosis Ticks off Parents

Dave Holt knew something was wrong. His daughter, Lucy, a talented soccer player and all-around normal, active, and outgoing 12-year-old girl, was not herself

May 20, 2019
·
2 min read
CureVac Enters into an Exclusive Sponsored Research Agreement for Discovery Research in mRNA-based Eye Therapy Candidates with the Schepens Eye Research Institute, Harvard Medical School and the Massachusetts Eye and Ear Infirmary

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced it has entered into a sponsored research agreement (“SRA”) with Schepens Eye Research Institute of Massachusetts Eye and Ear, a teaching hospital of Harvard Medical School, for discovery research in mRNA-based eye therapy candidates.

May 20, 2019
·
1 min read
Pharm Country

Micronic launches full range of hybrid tubes

Micronic widens the range of successful “hybrid” tubes. The leader in sample storage introduced 4 coding concepts, a tube with multiple sample identification methods, last year.

May 20, 2019
·
2 min read
Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing loss

Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1.4 million in seed funding.

May 20, 2019
·
6 min read
Genetown

MassBioEd Life Sciences Workforce Conference Brings Together Higher Education and Industry to Address Today’s Most Pressing Hiring & Retention Challenges

The Massachusetts Biotechnology Education Foundation’s (MassBioEd) 4th Annual Life Sciences Workforce Conference will advance discussion on workforce development issues related to the life sciences industry and will seek to increase engagement and collaboration between higher education and industry

May 20, 2019
·
2 min read
Biotech Bay

Adoption of SymphonyRM’s AI-Powered “Next Best Actions” Soars as Company Doubles Revenue and Client base and Raises $10 Million in Series A Financing

SymphonyRM, Healthcare’s Next Best Action (NBA) company, today announced that it has doubled its client base year over year.

May 20, 2019
·
3 min read
Drug Development

Allergy Therapeutics announces positive top line results from Phase I clinical study using Acarovac MPL

Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announces positive Phase I safety and tolerability results of subcutaneous Acarovac MPL (Monophosphoryl Lipid A) in patients with house dust mite (HDM)-induced allergic rhinoconjunctivitis.

May 20, 2019
·
3 min read